Clinical outcomes after lung transplantation for fibrosis in telomerase related genes mutation carriers

M. Phillips Houlbracq (Suresnes, France), H. Mal (Paris, France), V. Cottin (Lyon, France), F. Philit (Lyon, France), S. Hirschi (Strasbourg, France), A. Roux (Suresnes, France), L. Wémeau-Stervinou (Lille, France), J. Le Pavec ( Le Plessis-Robinson, France), C. Pison (Grenoble, France), S. Marchand Adam (Tours, France), A. Froidure (Bruxelles, Belgium), R. Lazor (Lausanne, Switzerland), J. Naccache (Paris, France), S. Jouneau (Rennes, France), H. Nunes (Bobigny, France), M. Reynaud-Gaubert (Marseille, France), A. Le Borgne (Toulouse, France), B. Crestani (Paris, France), C. Kannengiesser (Paris, France), R. Borie (Paris, France)

Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Session: Lung transplantation: from basic science to clinical outcomes
Session type: Poster Discussion
Number: 3365
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Phillips Houlbracq (Suresnes, France), H. Mal (Paris, France), V. Cottin (Lyon, France), F. Philit (Lyon, France), S. Hirschi (Strasbourg, France), A. Roux (Suresnes, France), L. Wémeau-Stervinou (Lille, France), J. Le Pavec ( Le Plessis-Robinson, France), C. Pison (Grenoble, France), S. Marchand Adam (Tours, France), A. Froidure (Bruxelles, Belgium), R. Lazor (Lausanne, Switzerland), J. Naccache (Paris, France), S. Jouneau (Rennes, France), H. Nunes (Bobigny, France), M. Reynaud-Gaubert (Marseille, France), A. Le Borgne (Toulouse, France), B. Crestani (Paris, France), C. Kannengiesser (Paris, France), R. Borie (Paris, France). Clinical outcomes after lung transplantation for fibrosis in telomerase related genes mutation carriers. 3365

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung transplantation in telomerase mutation carriers with pulmonary fibrosis
Source: Eur Respir J 2014; 44: 178-187
Year: 2014



Factors affecting lung function in adult cystic fibrosis patients after lung transplantation.
Source: International Congress 2018 – Evolving approaches to differential diagnosis
Year: 2018



Polymorphisms in immunosuppression transporters affect outcome after lung transplantation.
Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome
Year: 2017

Long-term outcomes and clinical worsening in cystic fibrosis patients with at least one residual function mutation
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018


Clinical characteristics and disease severity of adults with cystic fibrosis with at least one residual function mutation
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018


Survival and lung function in double lung transplant recipients with cystic fibrosis
Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome
Year: 2017

Does lung transplantation affect on the improvement of psychological status in patients with adult cystic fibrosis?
Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care
Year: 2018


Monogenic gene variants in lung transplant recipients with usual interstitial pneumonia
Source: ERJ Open Res, 8 (1) 00583-2021; 10.1183/23120541.00583-2021
Year: 2022



Immunophenotype and gene signature of long-term survivors with normal allograft function after lung transplantation
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019

Pulmonary fibrosis in non-mutation carriers of families with short telomere syndrome gene mutations.
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021



Gene expression markers to segregate lung transplant rejection phenotypes
Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD)
Year: 2017



Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure
Source: Eur Respir J 2015; 46: 1430-1439
Year: 2015



Clinical characteristics and pulmonary function in patients with pulmonary fibrosis assessed for lung transplant
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010


Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required?
Source: Eur Respir J 2014; 44: 270-271
Year: 2014


Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required?
Source: Eur Respir J 2014; 44: 269-270
Year: 2014


Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His
Source: ERJ Open Res, 3 (1) 00056-2016; 10.1183/23120541.00056-2016
Year: 2017



Patient reported quality of life in advanced cystic fibrosis (CF) lung disease assessed for lung transplantation
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008


Characteristics and prognostic relevance of p53 gene mutations in Polish non small cell lung cancer (NSCLC) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

Evaluation of MRP1-5 gene expression in cystic fibrosis patients homozygous for the ΔF508 mutation
Source: Annual Congress 2003 - Cystic fibrosis: new genes, new controversies
Year: 2003


Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis
Source: Eur Respir J 2016; 48: 1721-1731
Year: 2016